SoftOx Solutions AS (OL:SOFTX) — Market Cap & Net Worth
Market Cap & Net Worth: SoftOx Solutions AS (SOFTX)
SoftOx Solutions AS (OL:SOFTX) has a market capitalization of $33.36 Million (Nkr317.07 Million) as of October 12, 2026. Listed on the OL stock exchange, this Norway-based company holds position #23447 globally and #216 in its home market, demonstrating a -8.31% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SoftOx Solutions AS's stock price Nkr0.12 by its total outstanding shares 2659955723 (2.66 Billion).
SoftOx Solutions AS Market Cap History: 2018 to 2026
SoftOx Solutions AS's market capitalization history from 2018 to 2026. Data shows change from $6.30 Billion to $33.36 Million (-48.96% CAGR). Check current stock price of SoftOx Solutions AS for real-time trading data and today's change.
SoftOx Solutions AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SoftOx Solutions AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see SoftOx Solutions AS (SOFTX) cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.50x
SoftOx Solutions AS's market cap is 0.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $6.30 Billion | $4.32 Million | -$12.93 Million | 1456.77x | N/A |
| 2019 | $8.57 Billion | $4.10 Million | -$16.34 Million | 2089.53x | N/A |
| 2020 | $19.59 Billion | $9.84 Million | -$37.41 Million | 1991.35x | N/A |
| 2021 | $15.67 Billion | $7.90 Million | -$86.29 Million | 1983.88x | N/A |
| 2022 | $6.52 Billion | $7.11 Million | -$71.14 Million | 916.80x | N/A |
| 2023 | $906.89 Million | $6.98 Million | -$39.45 Million | 129.93x | N/A |
| 2024 | $3.92 Million | $7.91 Million | -$42.94 Million | 0.50x | N/A |
Competitor Companies of SOFTX by Market Capitalization
Companies near SoftOx Solutions AS in the global market cap rankings as of October 12, 2026. See SoftOx Solutions AS balance sheet independence to understand what proportion of total assets are financed by equity.
Key companies related to SoftOx Solutions AS by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #185 globally with a market cap of $129.29 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $75.50 Billion USD.
- CSL Ltd (AU:CSL): Ranked #448 globally with a market cap of $63.11 Billion USD ( AU$89.19 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #509 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #185 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $129.29 Billion | $510.08 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $75.50 Billion | $746.54 |
| #448 | CSL Ltd | AU:CSL | $63.11 Billion | AU$183.84 |
| #509 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $225.00 |
SoftOx Solutions AS Historical Marketcap From 2018 to 2026
Between 2018 and today, SoftOx Solutions AS's market cap moved from $6.30 Billion to $ 33.36 Million, with a yearly change of -48.96%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr33.36 Million | +35.76% |
| 2025 | Nkr24.58 Million | +527.14% |
| 2024 | Nkr3.92 Million | -99.57% |
| 2023 | Nkr906.89 Million | -86.09% |
| 2022 | Nkr6.52 Billion | -58.39% |
| 2021 | Nkr15.67 Billion | -20.00% |
| 2020 | Nkr19.59 Billion | +128.76% |
| 2019 | Nkr8.57 Billion | +36.00% |
| 2018 | Nkr6.30 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 12th, 2026 the market cap of SoftOx Solutions AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $33.36 Million USD |
| MoneyControl | $33.36 Million USD |
| MarketWatch | $33.36 Million USD |
| marketcap.company | $33.36 Million USD |
| Reuters | $33.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SoftOx Solutions AS
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway. The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, yeast, spores, and fungi. SoftOx So… Read more